Natural Alternatives Q3 net loss widens on factory underutilization

Natural Alternatives International

19/05/2026 11:23

Overview

Nutritional supplements maker's fiscal Q3 sales rose 23% yr/yr, net loss widened

Company cites underutilized factory capacity as main reason for operating loss

Management expects net loss for Q4 and full fiscal year

Outlook

Company expects fourth-quarter sales revenue to increase versus prior year

Company anticipates net loss for fourth quarter and full fiscal year 2026

Company says new credit facility provides flexibility to support anticipated sales growth

Result Drivers

FACTORY UNDERUTILIZATION - Co said operating loss was mainly due to underutilization of factory capacities

PRIVATE-LABEL SALES - Growth in net sales was mainly driven by increased orders from a major customer and shipments to new customers

CARNOSYN SALES FLAT - CarnoSyn beta-alanine royalty, licensing and raw material sales revenue were relatively flat at $1.7 million during the third quarter

Company press release: ID:nGNX4cw4QQ

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Sales
$35.48 mln
Q3 Net Income
-$4.31 mln
Q3 Gross Profit
$383,000
Q3 Operating Income
-$4.01 mln
Q3 Pretax Profit
-$4.24 mln


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)